Single award · contract
Venatorx Pharmaceuticals: Antibiotic for Amr and Biothreat Pathogens
Award ID: 75A50122C00080
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$72.1M
Total award value
Award 75A50122C00080 is a contract from the Department of Health and Human Services, $72.1M obligated, FY2022 to FY2029, for Venatorx Pharmaceuticals: Antibiotic for Amr and Biothreat Pathogens. The work is performed in Pennsylvania. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC 6505 (Drugs and Biologicals). Source
Award details
Award typeContract
PIID75A50122C00080
Action date2022
Period75 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performancePennsylvania →
CategoryNAICS 541714PSC 6505
Competed?Not recordedSource
Total (exact)$72,141,707
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.